Growth & Venture
  • LinkedIn
  • Twitter
  • Companies
    • Technology
    • Healthcare & Life Sciences
    • Growth Products & Services
    • A-Z List of Investments
  • How We Help
  • Team
    • View by Location/Role
    • A-Z List of Team Members
  • About
  • News
  • LinkedInTwitter
Credit
  • About
  • Approach
  • Team
Public Equity
  • About
  • Approach
  • Team
Life@Summit
Inspiration, ideas and insights for growth companies: View Resource Center >
Summit Partners
Growth & Venture
  • LinkedIn
  • Twitter
  • Companies
    • Technology
    • Healthcare & Life Sciences
    • Growth Products & Services
    • A-Z List of Investments
  • How We Help
  • Team
    • View by Location/Role
    • A-Z List of Team Members
  • About
  • News
  • LinkedInTwitter
Credit
  • About
  • Approach
  • Team
Public Equity
  • About
  • Approach
  • Team
Life@Summit
Team Members

THE SUMMIT TEAM

Luke ParsonsPrincipal

London

Phone: +44 (0)20 7659 7517

Email: Luke Parsons

Select Investments:
  • RadioOnkologieNetzwerk
  • Viroclinics Biosciences

Luke joined Summit in 2017 and focuses primarily on the healthcare & life sciences sector in Europe. His investment and board experience includes RadioOnkologieNetzwerk (acquired by Medipass) and Viroclinics Biosciences (acquired by Cerba Healthcare).

Prior to Summit, Luke served as Vice President in the Mergers & Acquisitions division of Jefferies.

Luke holds an MA in applied economics, with honors, from the University of St. Andrews.

Select Investments:
  • RadioOnkologieNetzwerk
  • Viroclinics Biosciences
Related News
Summit News Artboard 1
February 08, 2022

Summit Partners Announces Global Promotions

Portfolio News portfolio news icon Created using Figma
December 16, 2021

Cerba Healthcare to Acquire Viroclinics-DDL Expanding and Transforming Its Offering in Cl...

Cerba Healthcare to Acquire Viroclinics-DDL
Summit News Artboard 1
November 23, 2021

RadioOnkologieNetzwerk Acquired by Medipass

Dr. Sandra Roeddiger and Dr. Ralf Kurek, Co-CEOs, RadioOnkologieNetzwerk
Insights & Interests insights icon

Healthcare Trends: How Viroclinics-DDL is Accelerating the Development of Antiviral Thera...

Summit Partners Viroclinics
Summit News Artboard 1
March 03, 2020

Summit Partners Announces Growth Equity Investment in Viroclinics Biosciences

Viroclinics Summit Partners
Growth Equity for Exceptional Companies
    • © 2022 Summit Partners. All rights reserved.

    • Privacy
    • Legal Disclosures
    • Sitemap
    • Cookie Settings
    • Contact Summit Partners
    • LP Login
    • Portfolio Company Careers
    • Join Our Newsletter